HealthInternational News

Relief For Africa As Oxford Malaria Vaccine Gets Ready For Human Trial


The Oxford team that has produced a successful coronavirus vaccine is about to enter the final stage of human trials in its quest for inoculation against malaria, Sky News reports.

The Jenner Institute director, Prof Adrian Hill, said the malaria vaccine would be tested on 4,800 children in Africa next year after the early trials has yielded promising results.

Malaria is a public health emergency, more than 400,000 people a year die of the disease and in Africa, a child under five dies every two minutes.

“A lot more people will die in Africa this year from malaria than will die from Covid, i don’t mean twice as many probably 10 times, the vaccine is going to be available in very large amounts, it works pretty well and it’s going to be very low priced, Hill said.

”The vaccine could be in use by 2024 if the final human trials are successful, It is regarded as a potentially huge breakthrough given that no vaccine is fully licensed for malaria despite a century of research. GSK is the only pharmaceutical company to have gotten close but its product had only 30% efficacy, he added.

The institute’s coronavirus vaccine is also intended to be cheap and available at scale in developing countries, trials of the jab will start in Burkina Faso, Kenya, Tanzania and Mali next year. Early phase 2 trials look good so far and Oxford has joined with the serum institute in India to produce doses.

It comes as the Oxford AstraZeneca coronavirus vaccine awaits regulatory approval for use in the UK. Oxford researchers announced their vaccine had 62% efficacy in most volunteers compared with over 90% recorded for those produced by Pfizer and Moderna.

The researchers said however, that a sub-set of volunteers had mistakenly been given a lower dose of the vaccine as a result of manufacturing problems and that lower dosage produced a higher efficacy of about 90% but they had no explanation for the anomaly.

“The Covid-19 pandemic has demonstrated the extent to which the world remains at threat from infectious diseases, a highly effective vaccine against malaria could have a significant impact in reducing this risk, Azra Ghani a professor of infectious disease epidemiology at Imperial college London said.

APC wins Imo North Senatorial by-election without candidate 

Previous article

Osun governments to embark on massive rural electrification, says Oyetola

Next article

You may also like


Leave a Reply

More in Health